
The Chemours Company (CC) updated its Q2 2025 outlook, projecting consolidated net sales at the high end of original expectations with a mid-teens sequential increase, and consolidated adjusted EBITDA between $215 million and $225 million, with positive free cash flow. This guidance reflects strong performance in the Thermal & Specialized Solutions (TSS) segment, driven by Opteon Refrigerants demand and the U.S. AIM Act, anticipating a 25% sequential sales rise and 40% adjusted EBITDA growth. However, the Titanium Technologies (TT) segment expects a 15% sequential adjusted EBITDA decline due to approximately $25 million in operational disruptions and higher costs from rail line issues and other one-time events, alongside modestly higher corporate costs from ongoing litigation. Despite these varying segment performances, CC's stock has significantly underperformed, declining 51.5% over the past year, and currently holds a Zacks Rank #5 (Strong Sell).
The Chemours Company (CC) has issued a mixed second-quarter 2025 outlook, projecting consolidated net sales at the high end of its prior range with a mid-teens sequential increase, but with consolidated adjusted EBITDA now guided to $215-$225 million. The forecast reveals a sharp divergence in segment performance. The Thermal & Specialized Solutions (TSS) segment is a significant bright spot, anticipating a sequential net sales increase of approximately 25% and an adjusted EBITDA rise of roughly 40%, driven by strong demand for Opteon refrigerants under the regulatory tailwind of the U.S. AIM Act. The Advanced Performance Materials (APM) segment also shows strength, with adjusted EBITDA expected to grow 25% sequentially on better cost management. However, these positives are substantially offset by severe issues in the Titanium Technologies (TT) segment, which projects a 15% sequential decline in adjusted EBITDA. This decline is attributed to specific, one-time operational disruptions totaling approximately $25 million in incremental costs, stemming from a rail line disruption and other site-specific problems. Furthermore, ongoing litigation is expected to create a modest headwind on corporate costs. This operational and legal friction contributes to the stock's significant underperformance, having lost 51.5% over the past year against an industry decline of 24.7%, and its current Zacks Rank #5 (Strong Sell) rating.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly negative
Sentiment Score
-0.60
Ticker Sentiment